Supply Chain Ecosystem Analysis now part of DBMR Reports
Global Gynecology Robotic Surgery Market, By Product (Robotic Platform, Instrument and Accessories, Robotic Platform Services), Application (Hysterectomy, Sacrocolpopexy and Myomectomy, Gynecologic Malignancy), End- User (Hospitals and Clinics, Ambulatory Surgical Centers, Physician Centers) – Industry Trends and Forecast to 2029
Market Analysis and Size
In recent years, gynecology surgeries are surging globally because awareness about women’s health is growing and with that cases that needed surgeries are also rising that giving the boost to the gynecology robotic surgery market. Technological advancement in healthcare infrastructure and increasing investment are some of the major factor driving the gynecology robotic surgery market.
Data Bridge Market Research analyses that the gynecology robotic surgery market is expected to reach the value of USD 2.78 billion by the year 2029 during the forecast period. “Hospitals and Clinics” is the most dominating end use segment is one of the fastest growing segment in the market with growing rapid technology and investments in hospitals and clinics.
Market Definition
Surgical robotic systems include the use a variety of elements like instrumentality, software, accessories, and services. These robotic systems facilitate conducting many minimally-invasive surgeries like neurologic, gynaecological, cardiac, and medical science. The surgeons will automatize the surgical treatment with the assistance of robotic systems, which reinforces the effectualness and exactitude throughout the procedure and minimize the danger of any post-surgical complications. Surgeons work on inaccessible body elements victimization robotic systems as they're effective representations of body parts; it additionally will increase deftness.
Drivers
Ability to decrease the risk of blood loss
Not only robotic surgeries are very difficult to operate but these surgeries have their own benefits like it decreases the risk of blood loss in during surgery without losing much blood it increases the patient’s chances to survive and make a complete recovery after surgery.
Using gynecology robotic surgery decreases the chances of post- surgical complications
The robotics surgeries are very complex and it comes with its own risk but with the help of robotics it largely decreases the risk of post surgeries complications these procedures make left less scars on the body of patients.
Additionally, the, increasing demand for minimally invasive surgery among population, leave minimum scars and also provide faster recovery as comparted to the traditional surgery positively affect the gynecology robotic surgery market.
Opportunities
Furthermore, increasing cases of gynecological diseases in geriatric population and rising manufacturer focus to create more advanced products in the market will further expand the gynecology robotic surgery market's growth rate in the future.
Restraints/Challenges
On the other hand, high maintenance cost and installation cost of these systems and availability of substitute treatment are expected to obstruct market growth. Also, lack of skilled professionals are projected to challenge the gynecology robotic surgery market in the forecast period of 2022-2029.
This gynecology robotic surgery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the gynecology robotic surgery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The contagious coronavirus has a potential economic impact and implications on most of the sectors, including the medical device industries. Governments worldwide are now responding to the threat of COVID-19 with all the essential measures, such as social distancing, travel restrictions, and large-scale quarantines that are anticipated to impact the businesses and consumer spending negatively. The outbreak of COVID-19, resulted in decreased public mobility and have also impacted the therapeutic and surgical industry significantly, as the surgical procedures and screening programs, which are non-immediate and are being postponed to decrease the burden on healthcare infrastructure gynecology surgeries need a proper hospitals and operation theatre to perform and a whole staff to help and clean the operation theatre. Because of COVID -19 it was a big setback for these types of surgeries but now while covid cases are going down the gynecology robotic surgery cases are increasing and the market is recovering.
Recent Development
January 2020: Titan Medical and Cambridge Design Partnership (CDP) joined hands to develop a state-of-the-art robotic surgery system. Their main aim is to provide minimally invasive surgery through a single incision.
The gynecology robotic surgery market is segmented on the basis of product application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
On the basis of product, the gynecology robotic surgery market is segmented into robotic platform, instrument and accessories, and robotic platform services.
Application
On the basis of application, the gynecology robotic surgery market is segmented into hysterectomy, sacrocolpopexy and myomectomy and gynecologic malignancy.
End User
On the basis of end user, the gynecology robotic surgery market is segmented into hospitals and clinics, ambulatory surgical centers and physician centers.
The gynecology robotic surgery market is analysed and market size insights and trends are provided by country, product application and end user as referenced above.
The countries covered in the gynecology robotic surgery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the gynecology robotic surgery market because of the increasing demand for minimally invasive surgery among population within the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the growing awareness about women’s health and growing healthcare expenditure in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The gynecology robotic surgery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for gynecology robotic surgery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the gynecology robotic surgery market. The data is available for historic period 2010-2020.
The gynecology robotic surgery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to gynecology robotic surgery market.
Some of the major players operating in the gynecology robotic surgery market are BOWA-electronic GmbH & Co. KG, Prima Medical, XCELLANCE Medical Technologies, ATMOS MedizinTechnik GmbH & Co. KG, Ethicon US, LLC., Johnson & Johnson Services, Inc., Parkell, Inc., Smith + Nephew, Kirwan Surgical Products, LLC., Utah Medical Products, Inc., KLS Martin Group, Titan Medical Inc., Intuitive Surgical, TransEnterix Surgical, Inc., AVRA Medical Robotics, Inc, OmniGuide Holdings, Inc., CAE HEALTHCARE, Medrobotics Corporation., Medtronic, Simbionix USA Corporation among others.
SKU-
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL GYNECOLOGY ROBOTIC SURGERY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL GYNECOLOGY ROBOTIC SURGERY MARKET
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMAPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 TOP TO BOTTOM ANALYSIS
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 VENDOR SHARE ANALYSIS
2.2.10 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.11 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL GYNECOLOGY ROBOTIC SURGERY MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHT
5.1 PORTERS FIVE FORCES
5.2 REGULATORY STANDARDS
5.3 TECHNOLOGICAL TRENDS
5.4 PATENT ANALYSIS
5.5 CASE STUDY
5.6 VALUE CHAIN ANALYSIS
5.7 COMPANY COMPARITIVE ANALYSIS
5.8 RISKS INVOLVED IN ROBOT-ASSISTED GYNECOLOGIC SURGERIES
6 GLOBAL GYNECOLOGY ROBOTIC SURGERY MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 ROBOTIC PLATFORM
6.2.1 MULTI-INCISION
6.2.1.1. SINGLE BOOM
6.2.1.2. MODULAR
6.2.2 SINGLE-INCISION
6.2.2.1. TRANSUMBILICAL
6.2.2.2. TRANSVAGINAL
6.3 INSTRUMENTS & ACCESSORIES
6.3.1 SURGEON CONSOLE
6.3.2 PATIENT-SIDE CART WITH FOUR ROBOTIC ARMS
6.3.3 HIGH-DEFINITION 3D VSION SYSTEM
6.3.4 OTHERS
6.4 ROBOTIC PLATFORM SERVICES
6.4.1 INSTALLATION
6.4.2 SUPPORT & MAINTENANCE
6.4.3 OTHERS
7 GLOBAL GYNECOLOGY ROBOTIC SURGERY MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 ENDOMETRIOSIS RESECTION
7.3 TUBAL ANASTOMOSIS
7.4 HYSTERECTOMY
7.4.1 BY TYPE
7.4.1.1. BENIGN HYSTERECTOMY
7.4.1.2. RADICAL HYSTERECTOMY
7.4.2 BY CONDITION
7.4.2.1. UTERINE FIBROIDS
7.4.2.2. UTERINE PROLAPSE
7.4.2.3. ENDOMETRIOSIS
7.4.2.4. ABNORMAL VAGINAL BLEEDING
7.4.2.5. CHRONIC PELVIC PAIN
7.4.2.6. ADENOMYOSIS
7.4.2.7. OTHERS
7.5 MYOMECTOMY
7.6 SACROCOLPOPEXY
7.7 LYMPH NODE DISSECTION
7.7.1 BY TYPE
7.7.1.1. REGIONAL LYMPHADENECTOMY
7.7.1.2. RADICAL LYMPHADENECTOMY
7.7.2 BY DISSECTION SITES
7.7.2.1. AXILLARY LYMPH NODES
7.7.2.2. PELVIC LYMPH NODES
7.7.2.3. INGUINAL LYMPH NODES
7.7.2.4. CERVICAL LYMPH NODES
7.7.2.5. RETROPERITONEAL LYMPH NODES
7.7.2.6. OTHERS
7.8 GYNECOLOGIC CANCER
7.8.1 CERVICAL CANCER
7.8.2 OVARIAN CANCER
7.8.3 UTERINE CANCER
7.9 OTHERS
8 GLOBAL GYNECOLOGY ROBOTIC SURGERY MARKET, BY AGE GROUP
8.1 OVERVIEW
8.2 PEDIATRICS
8.3 ADULT
8.4 GERIATRIC
9 GLOBAL GYNECOLOGY ROBOTIC SURGERY MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 DIRECT SALES
9.3 RETAILS SALES
9.4 ONLINE SALES
9.5 OTHERS
10 GLOBAL GYNECOLOGY ROBOTIC SURGERY MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.2.1 BY HOSPITAL TYPE
10.2.1.1. PUBLIC HOSPITAL
10.2.1.1.1. BY TYPE
10.2.1.1.1.1 TIER 1
10.2.1.1.1.2 TIER 2
10.2.1.1.1.3 TIER 3
10.2.1.2. PRIVATE HOSPITAL
10.2.1.2.1. BY TYPE
10.2.1.2.1.1 TIER 1
10.2.1.2.1.2 TIER 2
10.2.1.2.1.3 TIER 3
10.2.2 BY PRODUCT
10.2.2.1. ROBOTIC PLATFORM
10.2.2.2. INSTRUMENTS & ACCESSORIES
10.2.2.3. ROBOTIC PLATFORM SERVICES
10.3 CLINICS
10.3.1 BY PRODUCT
10.3.1.1. ROBOTIC PLATFORM
10.3.1.2. INSTRUMENTS & ACCESSORIES
10.3.1.3. ROBOTIC PLATFORM SERVICES
10.4 AMBULATORY SURGICAL CENTERS
10.4.1 BY PRODUCT
10.4.1.1. ROBOTIC PLATFORM
10.4.1.2. INSTRUMENTS & ACCESSORIES
10.4.1.3. ROBOTIC PLATFORM SERVICES
10.5 OTHERS
11 GLOBAL GYNECOLOGY ROBOTIC SURGERY MARKET, BY GEOGRAPHY
GLOBAL GYNECOLOGY ROBOTIC SURGERY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
11.1 NORTH AMERICA
11.1.1 U.S.
11.1.2 CANADA
11.1.3 MEXICO
11.1.4 EUROPE
11.2 GERMANY
11.2.1 FRANCE
11.2.2 U.K.
11.2.3 ITALY
11.2.4 SPAIN
11.2.5 RUSSIA
11.2.6 TURKEY
11.2.7 BELGIUM
11.2.8 NETHERLANDS
11.2.9 NORWAY
11.2.10 FINLAND
11.2.11 SWITZERLAND
11.2.12 DENMARK
11.2.13 SWEDEN
11.2.14 POLAND
11.2.15 REST OF EUROPE
11.3 ASIA PACIFIC
11.3.1 JAPAN
11.3.2 CHINA
11.3.3 SOUTH KOREA
11.3.4 INDIA
11.3.5 AUSTRALIA
11.3.6 NEW ZEALAND
11.3.7 SINGAPORE
11.3.8 THAILAND
11.3.9 MALAYSIA
11.3.10 INDONESIA
11.3.11 PHILIPPINES
11.3.12 TAIWAN
11.3.13 VIETNAM
11.3.14 REST OF ASIA PACIFIC
11.4 SOUTH AMERICA
11.4.1 BRAZIL
11.4.2 ARGENTINA
11.4.3 REST OF SOUTH AMERICA
11.5 MIDDLE EAST AND AFRICA
11.5.1 SOUTH AFRICA
11.5.2 EGYPT
11.5.3 SAUDI ARABIA
11.5.4 U.A.E
11.5.5 OMAN
11.5.6 BAHRAIN
11.5.7 ISRAEL
11.5.8 KUWAIT
11.5.9 QATAR
11.5.10 REST OF MIDDLE EAST AND AFRICA
11.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
12 GLOBAL GYNECOLOGY ROBOTIC SURGERY MARKET,COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: GLOBAL
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
12.3 COMPANY SHARE ANALYSIS: EUROPE
12.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC
12.5 MERGERS & ACQUISITIONS
12.6 NEW PRODUCT DEVELOPMENT AND APPROVALS
12.7 EXPANSIONS
12.8 REGULATORY CHANGES
12.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
13 GLOBAL GYNECOLOGY ROBOTIC SURGERY MARKET, SWOT & DBMR ANALYSIS
14 GLOBAL GYNECOLOGY ROBOTIC SURGERY MARKET, COMPANY PROFILE
14.1 INTUITIVE SURGICAL
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENT
14.2 CMR SURGICAL
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENT
14.3 AVATERAMEDICAL GMBH.
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 PRODUCT PORTFOLIO
14.3.4 RECENT DEVELOPMENT
14.4 ASENSUS SURGICAL US, INC.
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENT
14.5 MEDTRONIC
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENT
14.6 OLYMPUS AMERICA
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENT
14.7 STRYKER
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENT
14.8 TITAN MEDICAL INC.
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
14.9 AVRA MEDICAL ROBOTICS, INC
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENT
14.1 ETHICON US, LLC
14.10.1 COMPANY SNAPSHOT
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENT
14.11 KARL STORZ GMBH & CO. KG
14.11.1 COMPANY SNAPSHOT
14.11.2 REVENUE ANALYSIS
14.11.3 PRODUCT PORTFOLIO
14.11.4 RECENT DEVELOPMENT
14.12 SMITH + NEPHEW
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENT
14.13 ZIMMER BIOMET
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENT
14.14 OMNIGUIDE HOLDINGS, INC.
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENT
14.15 UTAH MEDICAL PRODUCTS, INC.
14.15.1 COMPANY SNAPSHOT
14.15.2 REVENUE ANALYSIS
14.15.3 PRODUCT PORTFOLIO
14.15.4 RECENT DEVELOPMENT
14.16 KLS MARTIN GROUP.
14.16.1 COMPANY SNAPSHOT
14.16.2 REVENUE ANALYSIS
14.16.3 PRODUCT PORTFOLIO
14.16.4 RECENT DEVELOPMENT
14.17 GARNET HEALTH
14.17.1 COMPANY SNAPSHOT
14.17.2 REVENUE ANALYSIS
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPMENT
14.18 HOAG
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENT
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
15 CONCLUSION
16 QUESTIONNAIRE
17 RELATED REPORTS
18 ABOUT DATA BRIDGE MARKET RESEARCH
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.